Showing 1 - 7 results of 7 for search 'Azusa Nagao', query time: 0.03s Refine Results
  1. 1
    Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study

    Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study by Azusa Nagao, Ayumi Deguchi, Keiji Nogami

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study

    Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study by Azusa Nagao, Satoko Orita, Katsuyuki Fukutake, Hideyuki Takedani

    Published 2024-07-01
    Get full text
    Article
  3. 3
    Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study

    Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study by Azusa Nagao, Akiko Ioka, Takao Nakamura, Yoichi Murakami, Misako Makishima, Norihiro Okada, Michio Sakai

    Published 2022-10-01
    Get full text
    Article
  4. 4
    AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors

    AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congen... by Nobuaki Suzuki, Tadashi Matsushita, Keiji Nogami, Azusa Nagao, Chiai Nagae, Haruko Yamaguchi-Suita, Yui Kyogoku, Akiko Ioka

    Published 2022-03-01
    Get full text
    Article
  5. 5
    Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study

    Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study by Steven R. Lentz, Kaan Kavakli, Robert Klamroth, Mudi Misgav, Azusa Nagao, Alberto Tosetto, Pernille Juul Jørgensen, Marek Zak, Laszlo Nemes

    Published 2022-02-01
    Get full text
    Article
  6. 6
    AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, phase IV clinical study

    AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, pha... by Seitaro Yoshida, Masashi Taki, Hideyuki Takedani, Midori Shima, Keiji Nogami, Azusa Nagao, Haruko Yamaguchi-Suita, Yui Kyogoku, Akira Ishiguro, Kaoru Kitsukawa

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Utilizing artificial intelligence for the detection of hemarthrosis in hemophilia using point-of-care ultrasonography

    Utilizing artificial intelligence for the detection of hemarthrosis in hemophilia using point-of-care ultrasonography by Pascal N. Tyrrell, María Teresa Alvarez-Román, Nihal Bakeer, Brigitte Brand-Staufer, Victor Jiménez-Yuste, Susan Kras, Carlo Martinoli, Mauro Mendez, Azusa Nagao, Margareth Ozelo, Janaina B.S. Ricciardi, Marek Zak, Johannes Roth

    Published 2024-11-01
    Get full text
    Article

Search Tools: